BACK
Project/Company Name
VANTAGE therapeutics Company Limited
Project Leader
Source of Funding/Programme
TSSSU
Description
developing novel therapies targeting advanced glycation end products (AGEs), which play important pathological roles in chronic metabolic diseases and aging.
Project/Company Name
VANTAGE therapeutics Company Limited
Project Leader
Source of Funding/Programme
TSSSU
Description
developing novel therapies targeting advanced glycation end products (AGEs), which play important pathological roles in chronic metabolic diseases and aging.
Starting Year
2025
Business Area
Biotech
Nature
TSSSU Company